HomeNATHBIOGEN • NSE
add
Nath Bio-Genes (I) Ltd
Previous close
₹208.79
Day range
₹201.10 - ₹210.23
Year range
₹137.55 - ₹264.31
Market cap
3.87B INR
Avg Volume
38.59K
P/E ratio
10.25
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 519.68M | 20.35% |
Operating expense | 352.17M | -64.35% |
Net income | 14.81M | 32.39% |
Net profit margin | 2.85 | 10.04% |
Earnings per share | — | — |
EBITDA | 260.25K | -98.92% |
Effective tax rate | 40.01% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 888.99M | 14.84% |
Total assets | 10.26B | 16.58% |
Total liabilities | 3.82B | 41.25% |
Total equity | 6.44B | — |
Shares outstanding | 12.99M | — |
Price to book | 0.42 | — |
Return on assets | — | — |
Return on capital | -0.30% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 14.81M | 32.39% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1979
Website
Employees
423
